Elekta AB (EKTA B) - Financial and Strategic SWOT Analysis Review

August 2021 | 56 pages | ID: EB716D3C4B9EN
GlobalData

Abstracts

Elekta AB (EKTA B) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

• Business description – A detailed description of the company’s operations and business divisions.
• Corporate strategy – Analyst’s summarization of the company’s business strategy.
• SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
• Company history – Progression of key events associated with the company.
• Major products and services – A list of major products, services and brands of the company.
• Key competitors – A list of key competitors to the company.
• Key employees – A list of the key executives of the company.
• Executive biographies – A brief summary of the executives’ employment history.
• Key operational heads – A list of personnel heading key departments/functions.
• Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
• Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
• Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Elekta AB (Elekta) is a medical technology company that offers image guided clinical solutions, comprehensive information systems and services for the management of brain disorders and improved cancer care. Its major products include Gamma knife and Extend system; stereotactic system; fully integrated stereotactic radiation therapy system; system for volumetric arc modulated therapy; image guided radiation therapy systems; advanced digital treatment systems; treatment planning systems; electronic brachy therapy for skin cancer; and automated remote after loading platform. It also offers oncology information systems for radiation oncology and medical oncology, treatment planning software, cancer registry and soft tissue visualization software, among others. The company operates in North America, Europe, the Middle East, Africa and Asia-Pacific. Elekta is headquartered in Stockholm, Sweden.

Elekta AB Key Recent Developments

Aug 11,2021: Invitation to the presentation of Elekta's first quarter 2021/22
Jul 21,2021: Notice to the Annual General Meeting of Elekta
Jul 16,2021: Intermountain Healthcare provides notice of data security event
Jul 09,2021: Elekta's Annual Report for 2020/21 available
Jun 07,2021: Elekta's new strategy to focus on growth and access to radiation therapy

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.

• The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.

• The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.

• Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.

• Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.

• Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

Contents

SECTION 1 - ABOUT THE COMPANY

Elekta AB - Key Facts
Elekta AB - Key Employees
Elekta AB - Key Employee Biographies
Elekta AB - Major Products and Services
Elekta AB - History
Elekta AB - Company Statement
Elekta AB - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries

SECTION 2 – COMPANY ANALYSIS

Company Overview
Elekta AB - Business Description
Product Category: Service
Performance
Product Category: Solutions (includes hardware and software)
Performance
Geographical Segment: Asia Pacific
Performance
Geographical Segment: Europe, Middle East and Africa
Performance
Geographical Segment: North and South America
Performance
R&D Overview
Elekta AB - Corporate Strategy
Elekta AB - SWOT Analysis
SWOT Analysis - Overview
Elekta AB - Strengths
Elekta AB - Weaknesses
Elekta AB - Opportunities
Elekta AB - Threats
Elekta AB - Key Competitors

SECTION 3 – COMPANY FINANCIAL RATIOS

Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts

SECTION 4 – COMPANY’S LIFESCIENCES FINANCIAL DEALS AND ALLIANCES

Elekta AB, Medical Equipment, Deals By Year, 2015 to YTD 2021
Elekta AB, Medical Equipment, Deals By Type, 2015 to YTD 2021
Elekta AB, Recent Deals Summary

SECTION 5 – COMPANY’S RECENT DEVELOPMENTS

Aug 11, 2021: Invitation to the presentation of Elekta's first quarter 2021/22
Jul 21, 2021: Notice to the Annual General Meeting of Elekta
Jul 09, 2021: Elekta's Annual Report for 2020/21 available
Jun 07, 2021: Elekta's new strategy to focus on growth and access to radiation therapy
Jun 04, 2021: Elekta Nomination Committee's proposed Board of Directors for the 2021 Annual General Meeting
May 28, 2021: Elekta: Year-end report, May–April 2020/21
Apr 16, 2021: Elekta Report Extraordinary General Meeting on Friday 16 April 2021
Mar 19, 2021: Notice to the Extraordinary General Meeting of Elekta AB (publ)
Mar 08, 2021: Elekta wins lawsuit against Livian GmbH
Feb 25, 2021: Elekta appoints Johan Adeb?ck as chief financial officer

SECTION 6 – APPENDIX

Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List Of Tables

LIST OF TABLES

Elekta AB, Key Facts
Elekta AB, Key Employees
Elekta AB, Key Employee Biographies
Elekta AB, Major Products and Services
Elekta AB, History
Elekta AB, Other Locations
Elekta AB, Subsidiaries
Elekta AB, Key Competitors
Elekta AB, Ratios based on current share price
Elekta AB, Annual Ratios
Elekta AB, Annual Ratios (Cont...1)
Elekta AB, Annual Ratios (Cont...2)
Elekta AB, Interim Ratios
Elekta AB, Medical Equipment, Deals By Year, 2015 to YTD 2021
Elekta AB, Medical Equipment, Deals By Type, 2015 to YTD 2021
Elekta AB, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List Of Figures

LIST OF FIGURES

Elekta AB, Performance Chart (2017 - 2021)
Elekta AB, Ratio Charts
Elekta AB, Medical Equipment, Deals By Year, 2015 to YTD 2021
Elekta AB, Medical Equipment, Deals by Type, 2015 to YTD 2021